MetLife Investment Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833K | Buy |
|
|||||
|
2025
Q1 | $756K | Sell |
|
|||||
|
2024
Q4 | $796K | Buy |
|
|||||
|
2024
Q3 | $715K | Sell |
|
|||||
|
2024
Q2 | $582K | Buy |
|
|||||
|
2024
Q1 | $589K | Hold |
|
|||||
|
2023
Q4 | $567K | Hold |
|
|||||
|
2023
Q3 | $575K | Hold |
|
|||||
|
2023
Q2 | $617K | Buy |
|
|||||
|
2023
Q1 | $466K | Hold |
|
|||||
|
2022
Q4 | $786K | Hold |
|
|||||
|
2022
Q3 | $632K | Hold |
|
|||||
|
2022
Q2 | $696K | Buy |
|
|||||
|
2022
Q1 | $666K | Buy |
|
|||||
|
2021
Q4 | $398K | Hold |
|
|||||
|
2021
Q3 | $358K | Hold |
|
|||||
|
2021
Q2 | $264K | Buy |
|